Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
WISHES
NCT06339203Recruiting
- Sponsor
- Loma Linda University
- Start
- Jun 2024
- Primary completion
- Dec 2026
- Countries
- 1
01
Overview
Randomised, open-label trial of chlorhexidine in Cesarean section complication (CSC) and Infection (2 arms), sponsored by Loma Linda University. Primary endpoint: Composite wound evaluation scale at 8 weeks. Started Jun 2024; status: recruiting.
02
Drugs
chlorhexidine
03
Conditions
Cesarean section complication (CSC)Infection
Beyond the preview
Go deeper on NCT06339203.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06339203.